UBS Group’s bioAffinity Technologies BIAF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7 | Buy |
+24
| New | +$7 | ﹤0.01% | 8835 |
|
|
2024
Q3 | – | Sell |
-9,591
| Closed | -$20.7K | – | 8278 |
|
|
2024
Q2 | $20.7K | Buy |
+9,591
| New | +$20.7K | ﹤0.01% | 6128 |
|
|
2023
Q4 | – | Sell |
-65
| Closed | -$76 | – | 8082 |
|
|
2023
Q3 | $76 | Sell |
65
-30
| -32% | -$35 | ﹤0.01% | 7790 |
|
|
2023
Q2 | $174 | Sell |
95
-2,314
| -96% | -$4.24K | ﹤0.01% | 7341 |
|
|
2023
Q1 | $4.55K | Sell |
2,409
-4,172
| -63% | -$7.89K | ﹤0.01% | 7075 |
|
|
2022
Q4 | $10.5K | Buy |
6,581
+1,658
| +34% | +$2.65K | ﹤0.01% | 7306 |
|
|
2022
Q3 | $14K | Buy |
+4,923
| New | +$14K | ﹤0.01% | 6796 |
|